Novartis offers an additional $25 million in medical aid to Ukraine while suspending several operations in Russia – Endpoints News

As the war in Ukraine continues to escalate, pharmaceutical giant Novartis has detailed its campaign to offer humanitarian aid while sticking to a hard line against Russia.

Since the start of the invasion, Novartis has delivered more than one million boxes of antibiotics, painkillers, cardiovascular and oncology treatments to Ukraine, representing more than $25 million in medical aid, the company said in a statement.

The company is also maintaining its drug supplies for those in border areas where people are seeking refuge.

Novartis has already said Terminal News that it made an initial donation of $3 million to several NGOs, and that the company has “decided to suspend all investment in Russia and to stop all commercial marketing activities, as well as all scientific events, organized by us or by external parties”.

But Novartis is not alone in wanting to help Ukraine. Several other companies have taken steps to help while cutting ties with Russia, including AbbVie, Merck, Eli Lilly, Roche, Pfizer, Bayer and Sanofi, among others.

“We remain committed to providing access to medicines for patients in all countries where we operate,” Novartis said in a statement. “At the same time, we are ensuring compliance with international sanctions imposed on Russia.”

Novartis also said a set of measures have been implemented against Russia, including the suspension of capital investments, media advertising and other promotional activities in the country. Although the company remains committed to providing access to its drugs in Russia, it is suspending the initiation of new clinical trials and the recruitment of new participants to existing trials, although these measures remain under review.